Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2018 Filed Feb 2, 2018 19:47 UTC |
JOHNSON R MILTONDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 213,365 | $13.21 | $2,818,018.24 |
DisclosureSEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 2 JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC |
Hall Charles JGroup President
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 102,629 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,637 Underlying: Common Stock · 102,629 shares Expires 2019-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 35,949 | $103.09 | $3,706,154.97 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,544 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.33, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 33,744 | $102.24 | $3,449,986.56 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,493 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 102,629 | $22.64 | $2,323,674.50 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
SaleCommon Stock | 10,000 | $101.50 | $1,015,000.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 7 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT (Spouse, Trustee) Disclosed balance after: 0 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:33 UTC |
Chari Ravi S.SVP-Clinical Excellence
|
SaleCommon Stock | 568.0531 | $103.08 | $58,554.91 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,702 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:14 UTC |
YUSPEH ALAN RSVP & Chief Ethics Officer
|
GrantStock Appreciation Right · Derivative | 13,730 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007263 · doc4.xml · derivative · entry 2 YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,730 Underlying: Common Stock · 13,730 shares Expires 2028-01-31 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:14 UTC |
YUSPEH ALAN RSVP & Chief Ethics Officer
|
SaleCommon Stock | 15,000 | $100.61 | $1,509,151.50 |
DisclosureSEC source: 0001209191-18-007263 · doc4.xml · nonDerivative · entry 1 YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,656 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.32 to $100.75, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:14 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantStock Appreciation Right · Derivative | 18,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007261 · doc4.xml · derivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:13 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
GrantStock Appreciation Right · Derivative | 32,020 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007259 · doc4.xml · derivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,020 Underlying: Common Stock · 32,020 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantStock Appreciation Right · Derivative | 18,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · derivative · entry 8 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2028-01-31 F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · derivative · entry 7 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,437 Underlying: Common Stock · 1,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 6,250 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · derivative · entry 6 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 4,300 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · derivative · entry 5 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,300 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 5,871 | $101.16 | $593,910.36 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,735 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 7,750 | $37.18 | $288,145.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:12 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 4,300 | $22.95 | $98,685.00 |
DisclosureSEC source: 0001209191-18-007258 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:10 UTC |
STEAKLEY JOSEPH NSVP-Internal Audit Services
|
GrantStock Appreciation Right · Derivative | 13,730 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007255 · doc4.xml · derivative · entry 1 STEAKLEY JOSEPH N · CIK 0001216853 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,730 Underlying: Common Stock · 13,730 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
GrantStock Appreciation Right · Derivative | 27,450 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 15 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,450 Underlying: Common Stock · 27,450 shares Expires 2028-01-31 F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 50,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 14 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 50,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 13 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,505 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 12 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,505 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F2 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,505 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 11 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,505 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F2 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,505 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · derivative · entry 10 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,505 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F2 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 57,879 | $101.16 | $5,855,039.64 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · nonDerivative · entry 5 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,636 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 100,000 | $22.95 | $2,295,000.00 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · nonDerivative · entry 4 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 4,505 | $15.91 | $71,679.96 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · nonDerivative · entry 3 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 4,505 | $10.92 | $49,180.18 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · nonDerivative · entry 2 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:11 UTC |
STEELE JOHN MSVP & Chief Human Res. Officer
|
Exercise / conversionCommon Stock | 4,505 | $6.48 | $29,179.79 |
DisclosureSEC source: 0001209191-18-007257 · doc4.xml · nonDerivative · entry 1 STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 20:10 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantStock Appreciation Right · Derivative | 22,870 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007254 · doc4.xml · derivative · entry 4 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,870 Underlying: Common Stock · 22,870 shares Expires 2028-01-31 F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:55 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantStock Appreciation Right · Derivative | 70,900 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007239 · doc4.xml · derivative · entry 11 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,900 Underlying: Common Stock · 70,900 shares Expires 2028-01-31 F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantStock Appreciation Right · Derivative | 13,730 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 14 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,730 Underlying: Common Stock · 13,730 shares Expires 2028-01-31 F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 1,495 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 13 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,485 Underlying: Common Stock · 1,495 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 3,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 12 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 3,375 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 11 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 Underlying: Common Stock · 3,375 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 3,150 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 10 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,150 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 2,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 9 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 2,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · derivative · entry 8 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Tax withholdingCommon Stock | 9,475 | $101.16 | $958,491.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 6 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,545 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 2,020 | $102.00 | $206,040.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 5 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,020 F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 1,495 | $69.58 | $104,022.10 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 4 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 3,000 | $68.96 | $206,880.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 3 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 6,525 | $47.97 | $313,004.25 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 2 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:54 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 5,000 | $22.95 | $114,750.00 |
DisclosureSEC source: 0001209191-18-007238 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:52 UTC |
Paslick P. MartinSVP and CIO
|
GrantStock Appreciation Right · Derivative | 27,450 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007236 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,450 Underlying: Common Stock · 27,450 shares Expires 2028-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
GrantStock Appreciation Right · Derivative | 32,020 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 14 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,020 Underlying: Common Stock · 32,020 shares Expires 2028-01-31 F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 13 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F7 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,518 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 12 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,518 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:53 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,036 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001209191-18-007237 · doc4.xml · derivative · entry 11 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,036 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F6 · derivative.exercise_date: The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.